APA (7th ed.) Citation

Ippen, F., Hielscher, T., Patel, A., Göbel, K., Friedel, D., Maas, S., . . . Sahm, F. (2024). 482P The prognostic impact of CDKN2A/B heterozygous deletions in meningioma: Insights of a multicenter analysis. Annals of Oncology, 35, S421. https://doi.org/10.1016/j.annonc.2024.08.551

Chicago Style (17th ed.) Citation

Ippen, F.M, et al. "482P The Prognostic Impact of CDKN2A/B Heterozygous Deletions in Meningioma: Insights of a Multicenter Analysis." Annals of Oncology 35 (2024): S421. https://doi.org/10.1016/j.annonc.2024.08.551.

MLA (9th ed.) Citation

Ippen, F.M, et al. "482P The Prognostic Impact of CDKN2A/B Heterozygous Deletions in Meningioma: Insights of a Multicenter Analysis." Annals of Oncology, vol. 35, 2024, p. S421, https://doi.org/10.1016/j.annonc.2024.08.551.